Remove Clinic Remove Pharmaceutical Remove Ultrasound
article thumbnail

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Imaging Technology

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than Intravascular ultrasound (IVUS), making it ideal for clinical trials of cardi

article thumbnail

GE HealthCare posts flat revenues in Q3

AuntMinnie

GE HealthCare (GEHC) reported a 1% growth in existing operation revenues and an increase in profitability in its second quarter of 2024, citing solid performance in its Pharmaceutical Diagnostics segment. For the period (end-September 30), GEHC had total revenues of $4.86 billion, flat compared with $4.82 billion in the same period last year.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023

AuntMinnie

The research will produce technical feedback to assist GEHC in assessing the system’s reconstruction methods, image presentation workflow, and clinical benefits for specific pathologies and disease types. Other ultrasound scanners on display included GEHC’s Logiq E10, Fortis, Invenia ABUS 2.0, MRI GEHC unveiled Signa Champion, a 1.5-tesla,

article thumbnail

GE HealthCare and MediView Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite that Aims to Transform the Practice of Interventional Radiology

Imaging Technology

milla1cf Fri, 06/21/2024 - 20:24 June 21, 2024 — GE HealthCare , a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, and MediView XR Inc., Proceduralists must refer to standard of care imaging and prioritize clinical experience and/or judgment when using the OmnifyXR system.

article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. This includes continuing to grow MIM Software’s offerings for end-to-end standardization across large healthcare system fleets.

article thumbnail

Blue Earth Diagnostics, a Bracco Company, Appoints Marco Campione as Chief Executive Officer

Imaging Technology

Marco Campione brings more than 25 years of experience from GE HealthCare, where he most recently served as Executive Director and Global Head of Contrast Media, General Manager Pharmaceutical Diagnostics North America and President GE HealthCare Inc., according to a written statement announcing the appointment. “I

article thumbnail

US Radiology Specialists Tap Former GE HealthCare and United Healthcare Global Executives to Leadership Roles

Imaging Technology

He ended his tenure as President and CEO of GE Healthcare Systems in the United States and Canada, where he had responsibility for the core businesses of Imaging, Ultrasound, Life Care Solutions, and Enterprise Digital Solutions. Cooper spent nearly 30 years at GE, where he successfully led several business units.